Bosentan and Oral Anticoagulants in HIV Patients: What We Can Learn of Cases Reported So Far
Abstract
Share and Cite
Morales-Molina, J.A.; Martínez-de la Plata, J.E.; Urquízar-Rodríguez, O.; Molina-Arrebola, M.A. Bosentan and Oral Anticoagulants in HIV Patients: What We Can Learn of Cases Reported So Far. Hematol. Rep. 2011, 3, e16. https://doi.org/10.4081/hr.2011.e16
Morales-Molina JA, Martínez-de la Plata JE, Urquízar-Rodríguez O, Molina-Arrebola MA. Bosentan and Oral Anticoagulants in HIV Patients: What We Can Learn of Cases Reported So Far. Hematology Reports. 2011; 3(2):e16. https://doi.org/10.4081/hr.2011.e16
Chicago/Turabian StyleMorales-Molina, José Antonio, Juan Enrique Martínez-de la Plata, Olivia Urquízar-Rodríguez, and María Angustias Molina-Arrebola. 2011. "Bosentan and Oral Anticoagulants in HIV Patients: What We Can Learn of Cases Reported So Far" Hematology Reports 3, no. 2: e16. https://doi.org/10.4081/hr.2011.e16
APA StyleMorales-Molina, J. A., Martínez-de la Plata, J. E., Urquízar-Rodríguez, O., & Molina-Arrebola, M. A. (2011). Bosentan and Oral Anticoagulants in HIV Patients: What We Can Learn of Cases Reported So Far. Hematology Reports, 3(2), e16. https://doi.org/10.4081/hr.2011.e16